Brandt, Julia http://orcid.org/0000-0002-1303-4301
Warnke, Katharina
Jörgens, Silke
Arolt, Volker
Beer, Katja
Domschke, Katharina
Haverkamp, Wilhelm
Kuhlmann, Stella L.
Müller-Nordhorn, Jacqueline
Rieckmann, Nina
Schwarte, Kathrin
Ströhle, Andreas
Tschorn, Mira
Waltenberger, Johannes
Grosse, Laura
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01GY1154)
Article History
Received: 18 March 2020
Accepted: 10 August 2020
First Online: 29 August 2020
Compliance with ethical standards
:
: Volker Arolt declares that within the last three years of beginning this work he has received compensations for his contributions as member of advisory boards and for presentations for the following companies: Astra-Zeneca, Janssen-Organon, Lundbeck, Otsuka, Sanofi, Servier, and Trommsdorff. Wilhelm Haverkamp has been a member of the advisory boards or has given presentations on behalf of the following companies: Astra-Zeneca, Bayer, Boehringer Ingelheim, Daiichi Sankyo, Eli Lilly, Grünenthal, GlaxoSmithKline, Lundbeck, Medicines Company, MSD, Novartis, Pfizer, Trommsdorff and Servier. Andreas Ströhle received research funding from the German Federal Ministry of Education and Research, the German Research Foundation (DFG), the European Commission (FP6) and Lundbeck and speaker honoraria from AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly & Co, Lundbeck, Pfizer, Wyeth and UCB. He was a consultant for Actelion. Educational grants were given by the Stifterverband für die Deutsche Wissenschaft, the Berlin Brandenburgische Akademie der Wissenschaften, the Boehringer Ingelheim Fonds, the Eli Lilly International Foundation, Janssen-Cilag, Pfizer and Eli Lilly & Co. These co-operations have no relevance to the work that is covered in the manuscript. All other authors declare that they have no conflicts of interest.
: The study was approved by the respective ethics committees in Münster and Berlin.
: All subjects provided written informed consent to participate in the study.